Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization

FEMS Immunology and Medical Microbiology

Volumn 37, Issue 2-3, 2003, Pages 99-104

  Kang, Ho Young ^a,b   Curtiss III, Roy ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b Pusan National University   (South Korea)

Author keywords

Immune response; PspA antigen; Salmonella vaccine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; HISTIDINE; IMMUNOGLOBULIN G; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR DISTRIBUTION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOPLASM; EXPRESSION VECTOR; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; SALMONELLA TYPHIMURIUM; SINGLE DRUG DOSE; SPECIES COMPARISON;

EID: 0038433318     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00063-4     Document Type: Article

References (24)

1. Curtiss, R. III, Doggett, T., Nayak, A. and Srinivasan, J. (1996) Strategies for the use of live recombinant avirulent bacterial vaccines for mucosal immunization. In: Essentials of Mucosal Immunology (Kiyono, H. and Kagnoff, M.F., Eds.), pp. 499-511. Academic Press, San Diego, CA.
2. Medina E., Guzman C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine. 19:2001;1573-1580.
3. + expression-cloning vector: Stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology. 6:1988;693-697.
4. Gálan J.E., Nakayama K., Curtiss R. III. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene. 94:1990;29-35.
5. Kang H.Y., Srinivasan J., Curtisss R. III. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:2002;1739-1749.
6. Mufson, M.A. (1990) Streptococcus pneumoniae. In: Principles and Practice of Infectious Disease (Mandell, G.L., Douglas Jr., R.G. and Bennett, J.E., Eds.), pp. 1539-1550. Churchill Livingstone, New York.
7. Greenwood B. The epidemiology of pneumococcal infection in children in the developing world. Philos. Trans. R. Soc. Lond. B. 354:1999;777-785.
8. Hirschmann J.V. Use of the pneumococcal polysaccharide vaccine is unwarranted in the U.S. ASM News. 66:2000;326-327.
9. Briles D.E., King J.D., Gray M.A., McDaniel L.S., Swiatlo E., Benton K.A. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine. 14:1996;858-867.
10. Briles D.E., Hollingshead S.K., King J., Swift A., Braun P.A., Park M.K., Ferguson L.M., Nahm M.H., Nabors G.S. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182:2000;1694-1701.
11. Hollingshead S.K., Becker R., Briles D.E. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68:2000;5889-5900.
12. Briles D.E., Hollingshead S.K., Nabors G.S., Paton J.C., Brooks-Walter A. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine. 19:2001;S87-S95.
13. Briles D.E., Tart R.C., Swiatlo E., Dillard J.P., Smith P., Benton K.A., Ralph B.A., Brooks-Walter A., Crain M.J., Hollingshead S.K., McDaniel L.S. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:1998;645-657.
14. Nayak A.R., Tinge S.A., Tart R.C., McDaniel L.S., Briles D.E., Curtiss R. III. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immun. 66:1998;3744-3751.
15. Lennox E.S. Transduction of linked genetic characters of the host by bacteriophage P1. Virology. 1:1955;190-206.
16. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:1952;293-300.
17. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. McDaniel L.S., Scott G., Kearney J.F., Briles D.E. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160:1984;386-397.
19. Singh S.P., Upshaw Y., Abdullah T., Singh S.R., Klebba P.E. Structural relatedness of enteric bacterial porins assessed with monoclonal antibodies to Salmonella typhimurium OmpD and OmpC. J. Bacteriol. 174:1992;1965-1973.
20. Witholt B., Boekhout M., Brock M., Kingma J., van Heerikhuizen H., de Leij L. An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal. Biochem. 74:1976;160-170.
21. Gentschev I., Mollenkopf H., Sololovic Z., Hess J., Kaufmann S.H., Goebel W. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene. 179:1996;133-140.
22. Gentschev I., Glaser I., Goebel W., McKeever D.J., Musoke A., Heussler V.T. Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infect. Immun. 66:1998;2060-2064.
23. Janknecht R., de Martynoff G., Lou J., Hipskind R.A., Nordheim A., Stunnenberg H.G. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc. Natl. Acad. Sci. USA. 88:1991;8972-8976.
24. Oswald T., Wende W., Pingoud A., Rinas U. Comparison of N-terminal affinity fusion domains: effect on expression level and product heterogeneity of recombinant restriction endonuclease EcoRV. Appl. Microbiol. Biotechnol. 42:1994;73-77.